153 related articles for article (PubMed ID: 16082336)
1. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter.
Yu K; Chen Z; Wang S; Gorczynski R
Transplantation; 2005 Aug; 80(3):394-401. PubMed ID: 16082336
[TBL] [Abstract][Full Text] [Related]
2. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
3. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts.
Gorczynski RM; Chen Z; He W; Khatri I; Sun Y; Yu K; Boudakov I
J Immunol; 2009 Aug; 183(3):1560-8. PubMed ID: 19592654
[TBL] [Abstract][Full Text] [Related]
4. Persistence of gene expression profile in CD200 transgenic skin allografts is associated with graft survival on retransplantation to normal recipients.
Yu K; Gorczynski RM
Transplantation; 2012 Jul; 94(1):36-42. PubMed ID: 22683854
[TBL] [Abstract][Full Text] [Related]
5. sCD200 present in mice receiving cardiac and skin allografts causes immunosuppression in vitro and induces Tregs.
Gorczynski R; Chen Z; Khatri I; Yu K
Transplantation; 2013 Feb; 95(3):442-7. PubMed ID: 23380863
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200.
Boudakov I; Liu J; Fan N; Gulay P; Wong K; Gorczynski RM
Transplantation; 2007 Jul; 84(2):251-7. PubMed ID: 17667818
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Tolerance and Skin Allograft Survival in CD200tg Mice After Autologous Marrow Transplantation.
Gorczynski R; Chen Z; Khatri I; Yu K
Transplantation; 2014 Dec; 98(12):1271-8. PubMed ID: 25340612
[TBL] [Abstract][Full Text] [Related]
8. Use of the tetracycline system for inducible protein synthesis in the kidney.
Gallagher AR; Schönig K; Brown N; Bujard H; Witzgall R
J Am Soc Nephrol; 2003 Aug; 14(8):2042-51. PubMed ID: 12874458
[TBL] [Abstract][Full Text] [Related]
9. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
10. Generation and Characterization of Inducible Lung and Skin-Specific IL-22 Transgenic Mice.
Zhou L; Zheng T; Zhu Z
Methods Mol Biol; 2021; 2223():115-132. PubMed ID: 33226591
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
[TBL] [Abstract][Full Text] [Related]
13. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3(+)Treg and mast cells.
Gorczynski RM; Chen Z; Khatri I; Yu K
Transpl Immunol; 2011 Dec; 25(4):187-93. PubMed ID: 21801836
[TBL] [Abstract][Full Text] [Related]
14. Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 - and CSF-1R-expressing populations.
Pillai MM; Hayes B; Torok-Storb B
Exp Hematol; 2009 Dec; 37(12):1387-92. PubMed ID: 19772887
[TBL] [Abstract][Full Text] [Related]
15. Expression of green fluorescent protein in oligodendrocytes in a time- and level-controllable fashion with a tetracycline-regulated system.
Huang CJ; Spinella F; Nazarian R; Lee MM; Dopp JM; de Vellis J
Mol Med; 1999 Feb; 5(2):129-37. PubMed ID: 10203578
[TBL] [Abstract][Full Text] [Related]
16. Xenobiotic response in humanized double transgenic mice expressing tetracycline-controlled transactivator and human CYP1B1.
Hwang DY; Chae KR; Shin DH; Hwang JH; Lim CH; Kim YJ; Kim BJ; Goo JS; Shin YY; Jang IS; Cho JS; Kim YK
Arch Biochem Biophys; 2001 Nov; 395(1):32-40. PubMed ID: 11673863
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of immunosuppressive effects between human placental MSCs derived from fetal and maternal origins on the rejection of allogenic skin grafts in mice].
Hao G; Wang L; Chen D; Liang X; Wang Q; Zhu Y; Ma X; Liu X; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):609-14. PubMed ID: 25940286
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD200R2, anti-IL-9, anti-IL-35, or anti-TGF-β abolishes increased graft survival and Treg induction induced in cromolyn-treated CD200R1KO.CD200tg mice.
Gorczynski R; Yu K; Chen Z
Transplantation; 2014 Jan; 97(1):39-46. PubMed ID: 24142033
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
20. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.
Zhu Z; Ma B; Homer RJ; Zheng T; Elias JA
J Biol Chem; 2001 Jul; 276(27):25222-9. PubMed ID: 11331286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
